Article
Replication gaps underlie BRCA-deficiency and therapy response
2019-09-25
Abstract excerpt
Cancers that are deficient in BRCA1 or BRCA2 are hypersensitive to genotoxic agents, including platinums and other first-line chemotherapeutics. The established models propose that these cancers are hypersensitive because the chemotherapies block or degrade DNA replication forks and thereby create DNA double strand breaks, both of which require functional BRCA proteins to prevent or resolve by mechanisms termed fo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c1b48305-9dd2-5e2a-8cce-d7763035b155
- DOI
- 10.1101/781955
